EXCLUSIVE: Americans who suffered devastating side effects after taking GLP-1 drugs Ozempic and Wegovy tell Rhian Lubin why they are suing. “If someone would have told me ... a drug I was taking could ...

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection. Patients with a prescription could obtain the starter 1.5 mg dose of the tablet ...

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

Danish drugmaker Novo Nordisk is launching its once-daily Wegovy pill in the United States on Monday, offering 1.5 milligram and 4 mg doses at $149 per month for self-paying patients in an intensely ...

The weight-loss drug market just got more crowded — and a lot less painful. The FDA on Monday approved a daily pill version of Novo Nordisk’s Wegovy, making it the first oral GLP-1 obesity treatment ...

It’s normal to expect steady progress with a new weight loss treatment, and it can be discouraging when the results don’t match your hopes. So, if you’re frustrated with your Wegovy® journey because ...

Manufacturer Novo Nordisk has partnered with telehealth companies and other weight-loss groups to increase access to the pill, starting at $149 a month Novo Nordisk/FDA The Wegovy pill, which is ...

Days after hitting the market, the new pill version of Novo Nordisk’s wildly popular weight-loss drug will be available through Amazon’s online pharmacy. Amazon joins telehealth providers, discount ...

Wegovy is a prescription injection used for weight loss, to lower risk of cardiovascular problems, and to treat metabolic dysfunction-associated steatohepatitis (MASH). If you are prescribed Wegovy, ...

Novo Nordisk has launched the first once-daily GLP-1 weight-loss pill, an oral version of Wegovy approved by the FDA last month. Clinical trials showed the Wegovy pill delivered average weight loss of ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. The launch this week of an oral pill version of Wegovy ...